The aim of the current nationwide, multicentre Austrian study was to investigate systematically the intravenous administration of pantoprazole. The study objectives were to collect and evaluate ...
Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy and safety profile with IV pembrolizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback